Mannitol-containing macroporous calcium phosphate cement encapsulating human umbilical cord stem cells

Journal of Tissue Engineering and Regenerative Medicine

Volumn 6, Issue 3, 2012, Pages 214-224

  Tang, Minghui ^a   Weir, Michael D ^a   Xu, Hockin H K ^a,b,c,d  

^a UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

^d Baltimore County   (United States)

Author keywords

Bone tissue engineering; Calcium phosphate cement; Injectable scaffold; Macroporosity; Mannitol porogen; Umbilical cord stem cells

Indexed keywords

BONE; BONE CEMENT; CALCIUM PHOSPHATE; CELL ENGINEERING; CEMENTS; GENE EXPRESSION; POLYOLS; SCAFFOLDS (BIOLOGY); SETTING; STEM CELLS;

BONE TISSUE ENGINEERING; CALCIUM PHOSPHATE CEMENT; CELL/B.E; HUMAN UMBILICAL CORD; INJECTABLE SCAFFOLDS; MACRO-POROSITY; MANNITOL POROGEN; MESENCHYMAL STEM CELL; POROGENS; UMBILICAL CORD STEM CELLS;

CELL CULTURE;

ALKALINE PHOSPHATASE; CALCIUM PHOSPHATE; MANNITOL; OSTEOCALCIN;

ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL ENCAPSULATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; MINERALIZATION; NUCLEOTIDE SEQUENCE; POROSITY; PRIORITY JOURNAL; STEM CELL; TENSILE STRENGTH; UMBILICAL CORD STEM CELL;

EID: 84857502599     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.419     Document Type: Article

References (62)

1. Aoki T, Ohnishi H, Oda Y, et al. 2010; Generation of induced pluripotent stem cells from human adipose-derived stem cells without c-MYC. Tissue Eng A 16: 2197-2206.
2. ASTM (American Society for Testing and Materials). 2004; ASTM D 790-03: Standard test methods for flexural properties of unreinforced and reinforced plastic and electrical insulating materials. West Conshohocken, PA: ASTM International.
3. Atala A. 2009; Engineering organs. Curr Opin Biotechnol 20: 575-592.
4. Bailey MM, Wang L, Bode CJ, et al. 2007; A comparison of human umbilical cord matrix stem cells and temporomandibular joint condylar chondrocytes for tissue engineering temporomandibular joint condylar cartilage. Tissue Eng 13: 2003-2010.
5. Barralet JE, Gaunt T, Wright AJ, et al. 2002; Effect of porosity reduction by compaction on compressive strength and microstructure of calcium phosphate cement. J Biomed Mater Res B 63: 1-9.
6. Baksh D, Yao R, Tuan RS. 2007; Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 25: 1384-1392.
7. Benoit DSW, Nuttelman CR, Collins SD, et al. 2006; Synthesis and characterization of a fluvastatin-releasing hydrogel delivery system to modulate hMSC differentiation and function for bone regeneration. Biomaterials 27: 6102-6110.
8. Bodde EW, Habraken WJ, Mikos AG, et al. 2009; Effect of polymer molecular weight on the bone biological activity of biodegradable polymer/calcium phosphate cement composites. Tissue Eng A 15: 3183-3191.
9. Bohner M, Baroud G. 2005; Injectability of calcium phosphate pastes. Biomaterials 26: 1553-1563.
10. Borselli C, Storrie H, Bensch-Lee F, et al. 2010; Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors. Proc Natl Acad Sci USA 107: 3287-3292.
11. Brown WE, Chow LC. 1986; A new calcium phosphate water setting cement. In Cements Research Progress, Brown PW (ed.). American Ceramics Society: Westerville, OH; 352-379.
12. Burguera EF, Xu HHK, Weir MD. 2006; Injectable and rapid-setting calcium phosphate bone cement with dicalcium phosphate dihydrate. J Biomed Mater Res B 77: 126-134.
13. Can A, Karahuseyinoglu S. 2007; Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells. Stem Cells 25: 2886-2895.
14. Deville S, Saiz E, Nalla RK, et al. 2006; Freezing as a path to build complex composites. Science 311: 515-518.
15. Drury JL, Mooney DJ. 2003; Review. Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials 24: 4337-4351.
16. Drury JL, Dennis RG, Mooney DJ. 2004; The tensile properties of alginate hydrogels. Biomaterials 25: 3187-3199.
17. Ducheyne P, Qiu Q. 1999; Bioactive ceramics: the effect of surface reactivity on bone formation and bone cell function. Biomaterials 20: 2287-2303.
18. Foppiano S, Marshall SJ, Marshall GW, et al. 2004; The influence of novel bioactive glasses on in vitro osteoblast behavior. J Biomed Mater Res A 71: 242-249.
19. Friedman CD, Costantino PD, Takagi S, et al. 1998; BoneSource hydroxyapatite cement: a novel biomaterial for craniofacial skeletal tissue engineering and reconstruction. J Biomed Mater Res B 43: 428-432.
20. Gomes ME, Mikos AG, Reis RL. 2004; Injectable polymeric scaffolds for bone tissue engineering. In Biodegradable Systems in Tissue Engineering and Regenerative Medicine, Reis RL, San Roman J (eds). CRC Press: Boca Raton, FL; 29-38.
21. Hill EE, Boontheekul T, Mooney DJ. 2006; Regulating activation of transplanted cells controls tissue regeneration. Proc Natl Acad Sci USA 103: 2494-2499.
22. Jäger M, Degistirici O, Knipper A, et al. 2007; Bone healing and migration of cord blood-derived stem cells into a critical size femoral defect after xenotransplantation. J Bone Miner Res 22: 1224-1233.
23. Jansen JA, Vehof JWM, Ruhe PQ, et al. 2005; Growth factor-loaded scaffolds for bone engineering. J Control Release 101: 127-136.
24. Johnson PC, Mikos AG, Fisher JP, et al. 2007; Strategic directions in tissue engineering. Tissue Eng 13: 2827-2837.
25. Kim K, Dean D, Mikos AG, et al. 2009; Effect of initial cell seeding density on early osteogenic signal expression of rat bone marrow stromal cells cultured on cross-linked poly(propylene fumarate) disks. Biomacromolecules 10: 1810-1817.
26. Kong HJ, Smith MK, Mooney DJ. 2003; Designing alginate hydrogels to maintain viability of immobilized cells. Biomaterials 24: 4023-4029.
27. Kretlow JD, Young S, Klouda L, et al. 2009; Injectable biomaterials for regenerating complex craniofacial tissues. Adv Mater 21: 3368-3393.
28. Laurencin CT, Ambrosio AMA, Borden MD, et al. 1999; Tissue engineering: orthopedic applications. Annu Rev Biomed Eng 1: 19-46.
29. Lavik E, Langer R. 2004; Tissue engineering: current state and perspectives. Appl Microbiol Biotech 65: 1-8.
30. Leach JK, Kaigler D, Wang Z, et al. 2006; Coating of VEGF-releasing scaffolds with bioactive glass for angiogenesis and bone regeneration. Biomaterials 27: 3249-3255.
31. Livak KJ, Schmittgen TD. 2001; Analysis of relative gene expression data using real-time quantitative PCR and the method. Methods 25: 402-408.
32. Mao JJ, Giannobile WV, Helms JA, et al. 2006; Craniofacial tissue engineering by stem cells. J Dent Res 85: 966-979.
33. Mao JJ, Vunjak-Novakovic G, Mikos AG, et al. 2007; Regenerative Medicine: Translational Approaches and Tissue Engineering. Artech House: Boston, MA.
34. Markusen JF, Mason C, Hull DA, et al. 2006; Behavior of adult human mesenchymal stem cells entrapped in alginate-GRGDY beads. Tissue Eng 12: 821-830.
35. Martin RB, Chapman MW, Holmes RE, et al. 1989; Effects of bone ingrowth on the strength and non-invasive assessment of a coralline hydroxyapatite material. Biomaterials 10: 481-488.
36. Mikos AG, Herring SW, Ochareon P, et al. 2006; Engineering complex tissues. Tissue Eng 12: 3307-3339.
37. Moreau JL, Xu HHK. 2009; Mesenchymal stem cell proliferation and differentiation on an injectable calcium phosphate-chitosan composite scaffold. Biomaterials 30: 2675-2682.
38. Muzzarelli RAA, Biagini G, Bellardini M, et al. 1993; Osteoconduction exerted by methylpyrolidinone chitosan in dental surgery. Biomaterials 14: 39-43.
39. Nuttelman CR, Tripodi MC, Anseth KS. 2004; In vitro osteogenic differentiation of human mesenchymal stem cells photoencapsulated in PEG hydrogels. J Biomed Mater Res A 68: 773-782.
40. Praemer A, Furner S, Rice DP. 1999; Musculoskeletal Conditions in the United States. American Academy of Orthopedic Surgery: Rosemont, IL; Chapter 1.
41. Radin S, Reilly G, Bhargave G, et al. 2005; Osteogenic effects of bioactive glass on bone marrow stromal cells. J Biomed Mater Res A 73: 21-29.
42. Reilly GC, Radin S, Chen AT, et al. 2007; Differential alkaline phosphatase responses of rat and human bone marrow derived mesenchymal stem cells to 45S5 bioactive glass. Biomaterials 28: 4091-4097.
43. Salinas CN, Cole BB, Kasko AM, et al. 2007; Chondrogenic differentiation potential of human mesenchymal stem cells photoencapsulated within poly(ethylene glycol)-arginine-glycine-aspartic acid-serine thiol-methacrylate mixed-mode networks. Tissue Eng 13: 1025-1034.
44. Salinas CN, Anseth KS. 2008; The influence of the RGD peptide motif and its contextual presentation in PEG gels on human mesenchymal stem cell viability. J Tissue Eng Regen Med 2: 296-304.
45. Sarugaser R, Lickorish D, Baksh D, et al. 2005; Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells 23: 220-229.
46. Shi X, Sitharaman B, Pham QP, et al. 2007; Fabrication of porous ultra-short single-walled carbon nanotube nanocomposite scaffolds for bone tissue engineering. Biomaterials 28: 4078-4090.
47. Shindo ML, Costantino PD, Friedman CD, et al. 1993; Facial skeletal augmentation using hydroxyapatite cement. Arch Otolaryngol Head Neck Surg 119: 185-190.
48. Simon CG Jr, Guthrie WF, Wang FW. 2004; Cell seeding into calcium phosphate cement. J Biomed Mater Res A 68: 628-639.
49. Sundelacruz S, Kaplan DL. 2009; Stem cell- and scaffold-based tissue engineering approaches to osteochondral regenerative medicine. Semin Cell Dev Biol 20: 646-655.
50. Varghese S, Hwang NS, Ferran A, et al. 2010; Engineering musculoskeletal tissues with human embryonic germ cell derivatives. Stem Cells 28: 765-774.
51. Wang HS, Hung SC, Peng ST. 2004; Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 22: 1330-1337.
52. Wang L, Singh M, Bonewald LF, et al. 2009; Signaling strategies for osteogenic differentiation of human umbilical cord mesenchymal stromal cells for 3D bone tissue engineering. J Tissue Eng Regen Med 3: 398-404.
53. Wang YH, Liu Y, Maye P, et al. 2006; Examination of mineralized nodule formation in living osteoblastic cultures using fluorescent dyes. Biotechnol Prog 22: 1697-1701.
54. Weiss ML, Medicetty S, Bledsoe AR, et al. 2006; Human umbilical cord matrix stem cells: Preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 24: 781-792.
55. Weir MD, Xu HHK, Simon CG Jr. 2006; Strong calcium phosphate cement-chitosan-mesh construct containing cell-encapsulating hydrogel beads for bone tissue engineering. J Biomed Mater Res A 77: 487-496.
56. Weir MD, Xu HHK. 2010; Osteoblastic induction on calcium phosphate cement-chitosan constructs for bone tissue. J Biomed Mater Res A 94: 223-233.
57. Xu HHK, Quinn JB, Takagi S, et al. 2002; Processing and properties of strong and non-rigid calcium phosphate cement. J Dent Res 81: 219-224.
58. Xu HHK, Quinn JB. 2002; Calcium phosphate cement containing resorbable fibers for short-term reinforcement and macroporosity. Biomaterials 23: 193-202.
59. Xu HHK, Takagi S, Quinn JB, et al. 2004; Fast-setting and anti-washout calcium phosphate scaffolds with high strength and controlled macropore formation rates. J Biomed Mater Res A 68: 725-734.
60. Zhang Y, Xu HHK, Takagi S, et al. 2006; In situ hardening hydroxyapatite-based scaffold for bone repair. J Mater Sci Mater Med 17: 437-445.
61. Zhao L, Weir MD, Xu HHK. 2010a; Human umbilical cord stem cell encapsulation in calcium phosphate scaffolds for bone engineering. Biomaterials 31: 3848-3857.
62. Zhao L, Weir MD, Xu HHK. 2010b; An injectable calcium phosphate-alginate hydrogel-umbilical cord mesenchymal stem cell paste for bone tissue engineering. Biomaterials 31: 6502-6510.